Market Tracker

06/23 5:16pm ET

Amgen Inc (NASDAQ:AMGN)

172.50
Delayed Data
As of Jun 23
 -1.32 / -0.76%
Today’s Change
133.64
Today|||52-Week Range
184.21
+17.98%
Year-to-Date
How President Trump Has Sent Biotech Stocks Soaring
Jun 23 / TheStreet.com - Paid Partner Content
Amgen Defends Drug Pipeline, Says the Best is Yet to Come
Jun 21 / TheStreet.com - Paid Partner Content
Biotech Movers: Regeneron Slides Back After Big Gains
Jun 23 / TheStreet.com - Paid Partner Content
Novartis Migraine Drug Accepted, AMD Positive in Phase III
Jun 21 / Zacks.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Momentum?
Jun 22 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Ligand Gets Milestone Payment on Partner Drug FDA Approval
Jun 21 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
Dems Roast Trump for Leaving Medicare Out of Drug Price Order
Jun 21 / TheStreet.com - Paid Partner Content
Tracking Portfolio Performance With Risk Analysis
Jun 20 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close173.82
Today’s open173.24
Day’s range170.96 - 174.13
Volume14,368,474
Average volume (3 months)3,754,755
Market cap$126.9B
Dividend yield2.67%
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.76%
Earnings growth (next 5 years)+4.68%
Revenue growth (last year)+6.31%
P/E ratio16.4
Price/Sales4.86
Price/Book4.26

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.04+0.06%
BIIBBiogen-0.25-0.09%
ILMNIllumina Inc+2.29+1.25%
BIVVBioverativ Inc+1.60+2.62%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts